Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Clinical trial NCT00391053 · COMPLETED

Trial details

NCT number: NCT00391053
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Orthomyxoviridae Infection Influenza Myxovirus Infection

Start date: 2006-10-01
Primary completion: 2007-07-01
Enrollment: 3851

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.